Iovance Biotherapeutics, Inc. (IOVA)

Oncology Corporate Profile

Stock Performance

20.0000
0.0000

HQ Location

999 Skyway Rd.
San Carlos, CA 94070

Company Description

Iovance Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the development of cancer immunotherapy products for the treatment of various cancers. The Company's lead product candidate is an adoptive cell therapy using tumor-infiltrating lymphocyte (TIL) technology being investigated for the treatment of patients with metastatic melanoma, recurrent and/or metastatic squamous cell carcinoma of the head and neck and recurrent and metastatic or persistent cervical cancer. For more information, please visit http://www.iovance.com.

Website: http://www.iovance.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
LN-145adoptive cell transfer (ACT) therapyCervical cancerII
LN-145adoptive cell transfer (ACT) therapyHead & Neck cancerII
LN-144adoptive cell transfer (ACT) therapyMelanomaII

View additional information on product candidates here »

Source: http://www.iovance.com/

Recent News Headlines

There are no news items to display